We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
